<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ateroskleroz</journal-id><journal-title-group><journal-title xml:lang="ru">Атеросклероз</journal-title><trans-title-group xml:lang="en"><trans-title>Ateroscleroz</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-256X</issn><issn pub-type="epub">2949-3633</issn><publisher><publisher-name>НИИТПМ-филиал ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52727/2078-256X-2022-18-3-222-229</article-id><article-id custom-type="elpub" pub-id-type="custom">ateroskleroz-805</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Оценка клинических фенотипов больных ишемической болезнью сердца с пограничными стенозами коронарных артерий</article-title><trans-title-group xml:lang="en"><trans-title>Stable angina with intermedium coronary artery stenosis: the most typical clinical phenotypes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4735-5178</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яхонтов</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakhontov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Давыд Александрович Яхонтов - доктор медицинских наук, профессор кафедры фармакологии, клинической фармакологии и доказательной медицины.</p><p>630091, Новосибирск, Красный просп., 52</p></bio><bio xml:lang="en"><p>Davyd A. Yakhontov - doctor of medical sciences, professor of the department of pharmacology, clinical pharmacology and evidence-based medicine.</p><p>52, Krasny prosp., Novosibirsk, 630091</p></bio><email xlink:type="simple">mich99@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Останина</surname><given-names>Ю. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostanina</surname><given-names>Yu. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юлия Олеговна Останина - кандидат медицинских наук, доцент кафедры фармакологии, клинической фармакологии и доказательной медицины.</p><p>630091, Новосибирск, Красный просп., 52</p></bio><bio xml:lang="en"><p>Yuliya O. Ostanina - candidate of medical sciences, associate professor of the department of pharmacology, clinical pharmacology and evidence-based medicine.</p><p>52, Krasny prosp., Novosibirsk, 630091</p></bio><email xlink:type="simple">julia679@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дуничева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dunicheva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оксана Витальевна Дуничева - кандидат медицинских наук, главный врач ГБУЗ НСО НОККД, ассистент кафедра факультетской терапии им. проф. Г.Д. Залесского.</p><p>630091, Новосибирск, Красный просп., 52</p></bio><bio xml:lang="en"><p>Oksana V. Dunicheva - candidate of medical sciences, chief physician of the Novosibirsk Regional Cardiological Dispensary, assistant, department of Faculty Therapy named after prof. G.D. Zalessky.</p><p>52, Krasny prosp., Novosibirsk, 630091</p></bio><email xlink:type="simple">nokkd@nso.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1843-4232</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сурначева</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Surnacheva</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ольга Александровна Сурначева - студентка 6-го курса педиатрического факультета.</p><p>630091, Новосибирск, Красный просп., 52</p></bio><bio xml:lang="en"><p>Ol’ga А. Surnacheva - 6th year student of the faculty of pediatrics.</p><p>52, Krasny prosp., Novosibirsk, 630091</p></bio><email xlink:type="simple">olya_surna@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральное государственное бюджетное образовательное учреждение высшего образования Новосибирский государственный медицинский университет Министерства здравоохранения Российской Федерации<country>Россия</country></aff><aff xml:lang="en">Novosibirsk State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>29</day><month>09</month><year>2022</year></pub-date><volume>18</volume><issue>3</issue><fpage>222</fpage><lpage>229</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Яхонтов Д.А., Останина Ю.О., Дуничева О.В., Сурначева О.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Яхонтов Д.А., Останина Ю.О., Дуничева О.В., Сурначева О.А.</copyright-holder><copyright-holder xml:lang="en">Yakhontov D.A., Ostanina Y.O., Dunicheva O.V., Surnacheva O.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ateroskleroz.elpub.ru/jour/article/view/805">https://ateroskleroz.elpub.ru/jour/article/view/805</self-uri><abstract><p>Цель исследования – определить наиболее типичные фенотипы больных стабильной ишемической болезнью сердца (ИБС) с пограничными стенозами коронарных артерий (КА) с изучением факторов кардиоваскулярного риска и оценкой клинико-ангиографической картины.</p><sec><title>Материал и методы</title><p>Материал и методы. Обследовано 236 больных стабильной стенокардией функциональных классов I–III (190 мужчин; возраст 49–59 лет) с пограничными (40–70 %) стенозами КА. Всем пациентам проводились общеклиническое обследование, УЗИ сердца и коронароангиография. Дизайн исследования – сравнительное нерандомизированное описательное исследование четырех параллельных групп.</p></sec><sec><title>Результаты</title><p>Результаты. Преобладающими фенотипами больных стабильной ИБС с пограничными (40–70 %) стенозами КА оказались ИБС без перенесенного инфаркта миокарда (ИМ), ИБС с перенесенным ИМ давностью &lt; 6 месяцев, ИБС с метаболически нездоровым фенотипом ожирения (МНФО) без сахарного диабета (СД) и ИБС с СД 2 типа. Пациенты разных фенотипов значимо не различалась по частоте перенесенного в прошлом ИМ. Больные ИБС с МНФО, перенесшие ранее ИМ, отличались наиболее ранним возрастом его возникновения. Артериальная гипертензия (АГ) была у всех больных, однако пациенты с ИБС и СД 2 типа имели наибольшие значения индекса массы миокарда левого желудочка. У них же при ангиографическом исследовании наиболее часто регистрировалось многососудистое поражение КА. Несмотря на проводившееся амбулаторное лечение в течение года, у пациентов были повышены липидные и воспалительные показатели (содержание холестерина липопротеинов низкой плотности, триглицеридов, С-реактивного белка), а также наблюдалось большое количество лиц с недостаточным контролем артериального давления.</p></sec><sec><title>Заключение</title><p>Заключение. У больных стабильной стенокардией с пограничными стенозами КА, несмотря на отсутствие обструктивного поражения коронарного русла, риск кардиоваскулярных осложнений обусловлен практически стопроцентным наличием АГ, высокими значениями ИМТ, значительной частотой ожирения, дислипидемии, нарушений углеводного обмена, вследствие чего данные пациенты представляют собой достаточно серьезную группу лиц в плане плохого прогноза. Клинико-ангиографическая картина и уровень резидуального риска варьируются в зависимости от клинического фенотипа.</p></sec></abstract><trans-abstract xml:lang="en"><p>Aim of the study was to investigate the most typical phenotypes and to study cardiovascular risk factors and assess of the clinical angiographic picture in stable angina patients with intermedium coronary artery stenosis.</p><sec><title>Material and methods</title><p>Material and methods. 236 stable angina functional class I–III patients (190 men) aged 49–59 with intermedium (40–70 %) coronary artery stenosis were examined. A general clinical examination, ultrasound examination and coronary angiography were performed. Study design – non-randomized descriptive study of four parallel groups. Differences in the compared parameters were considered statistically significant at p &lt; 0.05.</p></sec><sec><title>Results</title><p>Results. The prevailing phenotypes in stable angina patients with intermedium coronary artery stenosis turned out to be coronary artery disease (CAD) without a previous myocardial infarction (MI); CAD with previous MI less than a 6 months ago; CAD with metabolically unhealthy obesity phenotype (MUOP) without diabetes mellitus (DM), and CAD with DM type 2. Patients of different phenotypes did not significantly differ in the frequency of past MI. CAD and MUOP patients with previous MI were characterized by the earliest age of its occurrence. Despite the 100 % availability of hypertension in different phenotypes groups, in CAD and DM type 2 patients were largest left ventricle myocardium mass values. They also had the most frequently recorded multivessel lesion during the coronary angiography study. Despite ongoing outpatient treatment for one year, the values of lipid and inflammation indices (content of low-density cholesterol, triglyceride, C-reactive protein) were high in all phenotypes patients as well as number of people with insufficient blood pressure control.</p></sec><sec><title>Conclusions</title><p>Conclusions. In stable angina patients with intermedium coronary artery stenosis despite the absence of obstructive coronary artery lesion, the cardiovascular complications risk is due to the presence of 100 % arterial hypertension, high body mass index, significant frequency of obesity, dyslipidemia, carbohydrates metabolism disorders. That is why such patients represent a rather serious group in terms of prognosis. The clinical and angiographic picture, as well as residual risk levels, vary depending on the clinical phenotype.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>пограничные стенозы</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>фенотипы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>borderline stenosis</kwd><kwd>coronary heart disease</kwd><kwd>phenotype</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tavella R., Beltrame J.F. Angina pectoris: how has the clinical presentation evolved? Is it still the same today as it was several years ago? J. Cardiol. Practice, 2017; 15: 1–19.</mixed-citation><mixed-citation xml:lang="en">Tavella R., Beltrame J.F. Angina pectoris: how has the clinical presentation evolved? Is it still the same today as it was several years ago? J. Cardiol. Practice, 2017; 15: 1–19.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Heberden W. Some account of a disorder of the breast. Medical Transactions of the Royal College of Physicians of London, 1772; 2: 59–62.</mixed-citation><mixed-citation xml:lang="en">Heberden W. Some account of a disorder of the breast. Medical Transactions of the Royal College of Physicians of London, 1772; 2: 59–62.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Parry C.H. An inquiry into the symptoms and causes of syncope anginosa, commonly called angina pectoris. Bath, 1799. 186 p.</mixed-citation><mixed-citation xml:lang="en">Parry C.H. An inquiry into the symptoms and causes of syncope anginosa, commonly called angina pectoris. Bath, 1799. 186 p.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gray C.R., Hoffman H.A., Hammond W.S., Miller K.L., Oseasohn R.O. Correlation of arteriographic and pathologic findings in the coronary arteries in man. Circulation, 1962; 26: 494–449.</mixed-citation><mixed-citation xml:lang="en">Gray C.R., Hoffman H.A., Hammond W.S., Miller K.L., Oseasohn R.O. Correlation of arteriographic and pathologic findings in the coronary arteries in man. Circulation, 1962; 26: 494–449.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Stefano G.T., Bezerra H.G., Attizzani G., Chamié D., Mehanna E., Yamamoto H., Costa M.A. Utilization of frequency domain optical coherence tomography and fractional flow reserve to assess intermediate coronary artery stenoses: conciliating anatomic and physiologic information. Int. J. Cardiovasc. Imaging, 2011; 27 (2): 299–308. doi: 10.1007/s10554-011-9847-9</mixed-citation><mixed-citation xml:lang="en">Stefano G.T., Bezerra H.G., Attizzani G., Chamié D., Mehanna E., Yamamoto H., Costa M.A. Utilization of frequency domain optical coherence tomography and fractional flow reserve to assess intermediate coronary artery stenoses: conciliating anatomic and physiologic information. Int. J. Cardiovasc. Imaging, 2011; 27 (2): 299–308. doi: 10.1007/s10554-011-9847-9</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Reeh J., Therming C.B., Heitmann M., Hojberg S., Sorum C., Bech J., Husum D., Dominguez H., Sehestedt T., Hermann T., Hansen K.W., Simonsen L., Galatius S., Prescott E. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur. Heart J., 2019; 40 (18): 1426–1435. doi: 10.1093/eurheartj/ehy806</mixed-citation><mixed-citation xml:lang="en">Reeh J., Therming C.B., Heitmann M., Hojberg S., Sorum C., Bech J., Husum D., Dominguez H., Sehestedt T., Hermann T., Hansen K.W., Simonsen L., Galatius S., Prescott E. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. Eur. Heart J., 2019; 40 (18): 1426–1435. doi: 10.1093/eurheartj/ehy806</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C., Prescott E., Storey R.F., Deaton C., Cuisset T., Agewall S., Dickstein K., Edvardsen T., Escaned J., Gersh B.J., Svitil P., Gilard M., Hasdai D., Hatala R., Mahfoud F., Masip J., Muneretto C., Valgimigli M., Achenbach S., Bax J.J., Group E.S.C.S.D. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J., 2020; 41 (3): 407–477. doi: 10.1093/eurheartj/ehz425</mixed-citation><mixed-citation xml:lang="en">Knuuti J., Wijns W., Saraste A., Capodanno D., Barbato E., Funck-Brentano C., Prescott E., Storey R.F., Deaton C., Cuisset T., Agewall S., Dickstein K., Edvardsen T., Escaned J., Gersh B.J., Svitil P., Gilard M., Hasdai D., Hatala R., Mahfoud F., Masip J., Muneretto C., Valgimigli M., Achenbach S., Bax J.J., Group E.S.C.S.D. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J., 2020; 41 (3): 407–477. doi: 10.1093/eurheartj/ehz425</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">D’Andrea A., Severino S., Mita C., Riegler L., Cocchia R., Gravino R., Castaldo F., Scarafile R., Salerno G., Pirone S., Calabro P., Bigazzi M.C., Citro R., Cuomo S., Caso P., Calabro R. Clinical outcome in patients with intermediate stenosis of left anterior descending coronary artery after deferral of revascularization on the basis of noninvasive coronary flow reserve measurement. Echocardiography, 2009; 26 (4): 431–440. doi: 10.1111/j.1540-8175.2008.00807.x</mixed-citation><mixed-citation xml:lang="en">D’Andrea A., Severino S., Mita C., Riegler L., Cocchia R., Gravino R., Castaldo F., Scarafile R., Salerno G., Pirone S., Calabro P., Bigazzi M.C., Citro R., Cuomo S., Caso P., Calabro R. Clinical outcome in patients with intermediate stenosis of left anterior descending coronary artery after deferral of revascularization on the basis of noninvasive coronary flow reserve measurement. Echocardiography, 2009; 26 (4): 431–440. doi: 10.1111/j.1540-8175.2008.00807.x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Einarson T.R., Acs A., Ludwig C., Panton U.H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc. Diabetol., 2018; 17 (1): 83. doi: 10.1186/s12933-018-0728-6</mixed-citation><mixed-citation xml:lang="en">Einarson T.R., Acs A., Ludwig C., Panton U.H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc. Diabetol., 2018; 17 (1): 83. doi: 10.1186/s12933-018-0728-6</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rahman H., Corcoran D., Aetesam-Ur-Rahman M., Hoole S.P., Berry C., Perera D. Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory. Heart, 2019; 105 (20): 1536– 1542. doi: 10.1136/heartjnl-2019-315042</mixed-citation><mixed-citation xml:lang="en">Rahman H., Corcoran D., Aetesam-Ur-Rahman M., Hoole S.P., Berry C., Perera D. Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory. Heart, 2019; 105 (20): 1536– 1542. doi: 10.1136/heartjnl-2019-315042</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wright A.K., Kontopantelis E., Emsley R., Buchan I., Mamas M.A., Sattar N., Ashcroft D.M., Rutter M.K. Cardiovascular risk and risk factor management in type 2 diabetes mellitus. Circulation, 2019; 139 (24): 2742– 2753. doi: 10.1161/CIRCULATIONAHA.118.039100</mixed-citation><mixed-citation xml:lang="en">Wright A.K., Kontopantelis E., Emsley R., Buchan I., Mamas M.A., Sattar N., Ashcroft D.M., Rutter M.K. Cardiovascular risk and risk factor management in type 2 diabetes mellitus. Circulation, 2019; 139 (24): 2742– 2753. doi: 10.1161/CIRCULATIONAHA.118.039100</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shao C., Wang J., Tian J., Tang Y.D. Coronary artery disease: from mechanism to clinical practice. Adv. Exp. Med. Biol., 2020; 1177: 1–36. doi: 10.1007/978981-15-2517-9_1</mixed-citation><mixed-citation xml:lang="en">Shao C., Wang J., Tian J., Tang Y.D. Coronary artery disease: from mechanism to clinical practice. Adv. Exp. Med. Biol., 2020; 1177: 1–36. doi: 10.1007/978981-15-2517-9_1</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Рекомендации ESC/EAS 2019 года по лечению дислипидемий: модификация липидов для снижения сердечно-сосудистого риска. Рабочая группа Европейского общества кардиологов (ESC) и Евро- пейского общества атеросклероза (EAS) по лечению дислипидемий. Научно-практический журнал, 2020; 16 (3): 61–81. doi: 10.15372/ATER20200308</mixed-citation><mixed-citation xml:lang="en">2019 ESC/EAS guidelines for the treatment of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Working Group on the Treatment of Dyslipidemias. Nauchno-prakticheskiy zhurnal, 2020; 16 (3): 61–81. doi: 10.15372/ATER20200308 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Рос. кардиол. журн., 2020; 25 (3): 3786. doi: 10.15829/1560-4071-2020-3-3786</mixed-citation><mixed-citation xml:lang="en">Arterial hypertension in adults. Clinical guidelines 2020. Rossiyskiy kardiologicheskiy zhurnal, 2020; 25 (3): 3786. doi: 10.15829/1560-4071-2020-3-3786 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H.W., Jin J.L., Cao Y.X., Guo Y.L., Wu N.Q., Zhu C.G., Xu R.X., Dong Q., Li J.J. Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis. Cardiovasc. Diabetol., 2021; 20 (1): 214. doi: 10.1186/s12933-02101403-6</mixed-citation><mixed-citation xml:lang="en">Zhang H.W., Jin J.L., Cao Y.X., Guo Y.L., Wu N.Q., Zhu C.G., Xu R.X., Dong Q., Li J.J. Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis. Cardiovasc. Diabetol., 2021; 20 (1): 214. doi: 10.1186/s12933-02101403-6</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Desai N.R., Bradley S.M., Parzynski C.S., Nallamothu B.K., Chan P.S., Spertus J.A., Patel M.R., Ader J., Soufer A., Krumholz H.M., Curtis J.P. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA, 2015; 314 (19): 2045–2053. doi: 10.1001/jama.2015.13764</mixed-citation><mixed-citation xml:lang="en">Desai N.R., Bradley S.M., Parzynski C.S., Nallamothu B.K., Chan P.S., Spertus J.A., Patel M.R., Ader J., Soufer A., Krumholz H.M., Curtis J.P. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA, 2015; 314 (19): 2045–2053. doi: 10.1001/jama.2015.13764</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hannan E.L., Samadashvili Z., Cozzens K., Gesten F., Osinaga A., Fish D.G., Donahue C.L., Bass R.J., Walford G., Jacobs A.K., Venditti F.J., Stamato N.J., Berger P.B., Sharma S., King S.B. Changes in percutaneous coronary interventions deemed “inappropriate” by appropriate use criteria. J. Am. Coll. Cardiol., 2017; 69 (10): 1234–1242. doi: 10.1016/j.jacc.2016.12.025</mixed-citation><mixed-citation xml:lang="en">Hannan E.L., Samadashvili Z., Cozzens K., Gesten F., Osinaga A., Fish D.G., Donahue C.L., Bass R.J., Walford G., Jacobs A.K., Venditti F.J., Stamato N.J., Berger P.B., Sharma S., King S.B. Changes in percutaneous coronary interventions deemed “inappropriate” by appropriate use criteria. J. Am. Coll. Cardiol., 2017; 69 (10): 1234–1242. doi: 10.1016/j.jacc.2016.12.025</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
